Nobel Prize 2025 - November 21, 2025
A delicate balance between defense and self-harm
The Nobel Prize in Physiology or Medicine 2025 honors fundamental discoveries about how the body prevents the immune system from doing harm, leading to important medical progress in autoimmune diseases and cancer.
Sweden - November 18, 2025
US tariffs threaten Swedish patients’ access to medicines, states Lif
Almost six out of ten Swedes believe that their future access to important medicines could be greatly affected by the US tariff plans.
Biotech Business - November 18, 2025
Sofinnova announces USD 750M fund that will invest in early stage biotechs
European life science VC firm Sofinnova Partners has announced the close of its latest flagship fund, Sofinnova Capital XI, at EUR 650 million (USD 750 million).
Business article - November 18, 2025
#WAAW: Fighting AMR: Nordic efforts
Antimicrobial resistance is one of the world’s most severe global health threats but there is still hope, including several Nordic innovative solutions.
Collaboration - November 18, 2025
TIRmed Pharma collaborates with Bachem
The collaboration includes process development and manufacturing of TIR-01, the active substance in TIRmed’s treatment for atopic dermatitis (eczema), and marks an important step towards future clinical trials.
Sweden - November 18, 2025
#WAAW: The Swedish government’s new strategy against AMR
This strategy, presented yesterday by the Minister of Health and Social Affairs, Jakob Forssmed, has a 10-year perspective in order to create predictability and sustainability in the continued work.
